Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (12)

Oct 6, 2026patentUS 7741358*PED91d
Oct 6, 2026patentUS 7741358*PED91d
Oct 6, 2026patentUS 7741358*PED91d
Oct 6, 2026patentUS 8022228*PED91d
Oct 6, 2026patentUS 8022228*PED91d
Oct 6, 2026patentUS 8022228*PED91d
Apr 6, 2026compositionUS 7741358
Apr 6, 2026compositionUS 7741358
Apr 6, 2026compositionUS 7741358
Apr 6, 2026compositionUS 8022228
Apr 6, 2026compositionUS 8022228
Apr 6, 2026compositionUS 8022228

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 1

tagApproval4 co-mentions · 2 sources